Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Final Verdict: 7 Clinical Facts Ozempic is not licensed for weight loss in the UK Wegovy is the licensed semaglutide weight management product Mounjaro and Wegovy are different drugs tirzepatide (dual GLP-1/GIP) vs semaglutide (GLP-1 only) In the SURMOUNT-5 head-to-head trial, Mounjaro produced 20.2% vs Wegovys 13.7% average weight loss Wegovy is approximately 75/month cheaper at Slinic maintenance doses important for cost-sensitive patients Wegovy has the NICE cardiovascular indication (April 2026) Mounjaro does not yet have this label Wegovy now has a licensed oral version (MHRA June 2026) Mounjaro does not yet have an oral equivalent Neither Ozempic off-label nor compounded alternatives are appropriate when licensed products are readily available from a GPhC-registered UK pharmacy Slinic prescribes Mounjaro and Wegovy both correctly licensed, both from Eli Lilly and Novo Nordisk authorised supply chains, both reviewed by a registered UK prescriber
After reconstitution, aliquot to prevent repeated freezethaw cycles
Yes, GLP-1 medications can generally be used in patients with high blood pressure, though careful provider oversight is essential
Egilman AC, Kesselheim AS, Krumholz HM , Ross JS, Kim J, Kapczynski A
Currently, Ozempic remains solely FDA-approved for Type 2 Diabetes, while Wegovy is FDA-approved for chronic weight management
If you have a strained bicep tendon, it's important not to aggravate the injury any further
